TapewireFind a company

person · Reporting owner

Hirsch Susan B

Disclosed activity across 2 companies

Tapewire entity
25556
SEC CIK
0001827663

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
AGENUS INCAGEN · Entity 5774DirectorAugust 05, 2026August 07, 2026
TECOGEN INC.TGEN · Entity 6846DirectorJune 26, 2026July 01, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AGENUS INC

Report date August 05, 2026 · Filed August 07, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.78 · Expires 2036-08-05Direct50,000 Reported balance After 2026-08-05 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-08-05 · Grant · Acquired 50,000 · Balance 50,000

F1: Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter.

Filing footnotes · ownership attribution and instrument terms

F1: Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter.

TECOGEN INC.

Report date June 26, 2026 · Filed July 01, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.17 · Expires 2036-06-26Direct25,000 Reported balance After 2026-06-26 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-26 · Grant · Acquired 25,000 · Balance 25,000

F1: Vests 25% per year

Filing footnotes · ownership attribution and instrument terms

F1: Vests 25% per year

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 05, 2026 Filed Aug 7, 2026 18:16 UTC AGENUS INC AGEN · Entity 5774 GrantStock Option · Derivative 50,000 $0.00 Strike: $7.78 $0.00
Disclosure

SEC source: 0001193125-26-339968 · ownership.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-08-05

F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter.

Read SEC document
June 26, 2026 Filed Jul 1, 2026 00:34 UTC TECOGEN INC. TGEN · Entity 6846 GrantStock Option (Right to Buy) · Derivative 25,000 $5.17 Strike: $5.17 $129,250.00
Disclosure

SEC source: 0001537435-26-000046 · wk-form4_1782866039.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-06-26

F1 · derivative.exercise_date: Vests 25% per year

Read SEC document
April 24, 2026 Filed Apr 28, 2026 20:15 UTC AGENUS INC AGEN · Entity 5774 GrantStock Option · Derivative 105,000 $0.00 Strike: $3.90 $0.00
Disclosure

SEC source: 0001193125-26-187090 · ownership.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,000

Underlying: Common Stock · 105,000 shares

Expires 2036-04-24

F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date.

Read SEC document
April 13, 2026 Filed Apr 14, 2026 20:03 UTC TECOGEN INC. TGEN · Entity 6846 PurchaseCommon Stock 5,000 $3.73 $18,650.00
Disclosure

SEC source: 0001827663-26-000004 · wk-form4_1776197000.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,416

Read SEC document
March 27, 2026 Filed Mar 27, 2026 20:24 UTC TECOGEN INC. TGEN · Entity 6846 PurchaseCommon Stock 10,000 $2.54 $25,400.00
Disclosure

SEC source: 0001827663-26-000002 · wk-form4_1774643070.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 260,416

Read SEC document
July 24, 2025 Filed Jul 28, 2025 15:02 UTC TECOGEN INC. TGEN · Entity 6846 GrantStock Option (Right to Buy) · Derivative 25,000 $8.35 Strike: $8.35 $208,750.00
Disclosure

SEC source: 0001537435-25-000117 · wk-form4_1753714943.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 25,000 shares

Expires 2035-07-24

F1 · derivative.exercise_date: Vests 25% per year

Read SEC document
June 17, 2025 Filed Jun 20, 2025 20:10 UTC AGENUS INC AGEN · Entity 5774 GrantStock Option · Derivative 15,000 $0.00 Strike: $3.02 $0.00
Disclosure

SEC source: 0000950170-25-088504 · ownership.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2035-05-28

F1 · derivative.exercise_date: Options were granted on May 28, 2025 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 17, 2025. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date.

Read SEC document
January 01, 2025 Filed Jan 2, 2025 21:05 UTC AGENUS INC AGEN · Entity 5774 GrantDeferred Stock Units · Derivative 6,416.074 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-000403 · ownership.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,206.567

Underlying: Common Stock · 6,416.074 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $3.70 per Deferred Stock Unit acquired on January 2, 2025. The price of each Deferred Stock Unit acquired on January 2, 2025 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 12:38 UTC AGENUS INC AGEN · Entity 5774 GrantDeferred Stock Units · Derivative 3,172.98 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-112004 · ownership.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,790.493

Underlying: Common Stock · 3,172.98 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $7.49 per Deferred Stock Unit acquired on October 1, 2024. The price of each Deferred Stock Unit acquired on October 1, 2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
July 01, 2024 Filed Jul 1, 2024 20:05 UTC AGENUS INC AGEN · Entity 5774 GrantDeferred Stock Units · Derivative 1,827.956 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-079584 · ownership.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,617.513

Underlying: Common Stock · 1,827.956 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $12.08 per Deferred Stock Unit acquired on July 1, 2024. The price of each Deferred Stock Unit acquired on July 1, 2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
June 06, 2024 Filed Jun 18, 2024 19:52 UTC TECOGEN INC. TGEN · Entity 6846 GrantStock Options (Right to Buy) · Derivative 25,000 $0.77 Strike: $0.77 $19,250.00
Disclosure

SEC source: 0001537435-24-000086 · wk-form4_1718740331.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 25,000 shares

Expires 2034-06-06

F1 · derivative.exercise_date: Vests 25% per year

Read SEC document
April 01, 2024 Filed Apr 1, 2024 20:23 UTC AGENUS INC AGEN · Entity 5774 GrantDeferred Stock Units · Derivative 32,039.161 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-039357 · ownership.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,791.152

Underlying: Common Stock · 32,039.161 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $0.66 per Deferred Stock Unit acquired on April 1, 2024. The price of each Deferred Stock Unit acquired on April 1, 2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
February 05, 2024 Filed Apr 22, 2024 20:05 UTC AGENUS INC AGEN · Entity 5774 GrantStock Option · Derivative 5,000 $0.00 Strike: $12.60 $0.00
Disclosure

SEC source: 0000950170-24-046420 · ownership.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2034-02-05

F1 · derivative.exercise_date: The Stock Options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan on February 5, 2024 and will vest on February 5, 2025. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 100,000 Stock Options with an exercise price of $0.63.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 11:06 UTC AGENUS INC AGEN · Entity 5774 GrantDeferred Stock Units · Derivative 25,671.141 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-001479 · ownership.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,751.991

Underlying: Common Stock · 25,671.141 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $0.83 per Deferred Stock Unit acquired on January 2, 2024. The price of each Deferred Stock Unit acquired on October 2, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
November 15, 2023 Filed Feb 12, 2024 12:00 UTC AGENUS INC AGEN · Entity 5774 OtherCommon Stock 5,000 $0.75 $3,750.00
Disclosure

SEC source: 0000950170-24-013560 · ownership.xml · nonDerivative · entry 2

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,725

F1 · shares: Represents open market purchase of common stock for cash.

Read SEC document
November 14, 2023 Filed Feb 12, 2024 12:00 UTC AGENUS INC AGEN · Entity 5774 OtherCommon Stock 5,000 $0.67 $3,350.00
Disclosure

SEC source: 0000950170-24-013560 · ownership.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,725

F1 · shares: Represents open market purchase of common stock for cash.

Read SEC document
October 19, 2023 Filed Oct 20, 2023 22:14 UTC TECOGEN INC. TGEN · Entity 6846 PurchaseCommon Stock 5,000 $0.92 $4,575.00
Disclosure

SEC source: 0001537435-23-000141 · wk-form4_1697840034.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,416

Read SEC document
October 02, 2023 Filed Oct 4, 2023 21:11 UTC AGENUS INC AGEN · Entity 5774 GrantDeferred Stock Units · Derivative 14,927.713 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-23-051969 · ownership.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,080.85

Underlying: Common Stock · 14,927.713 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $1.42 per Deferred Stock Unit acquired on October 2, 2023. The price of each Deferred Stock Unit acquired on October 2, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediat1ely preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. This amount also includes a downward adjustment of 62.21 Deferred Stock Units in respect of the grant dated July 3, 2023, as the average closing price used for such calculation incorrectly reflected a stock split and was increased on October 2, 2023 to $1.61 per Deferred Stock Unit.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
July 03, 2023 Filed Jul 6, 2023 20:30 UTC AGENUS INC AGEN · Entity 5774 GrantDeferred Stock Units · Derivative 13,283.487 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-23-017125 · doc4.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,153.14

Underlying: Common Stock · 13,283.487 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $1.60 per Deferred Stock Unit acquired on July 3, 2023. The price of each Deferred Stock Unit acquired on July 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediat1ely preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
April 03, 2023 Filed Apr 3, 2023 19:59 UTC AGENUS INC AGEN · Entity 5774 GrantDeferred Stock Units · Derivative 9,869.6532 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-23-010208 · doc4.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,869.6532

Underlying: Common Stock · 9,869.6532 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $2.153 per Deferred Stock Unit acquired on April 3, 2023. The price of each Deferred Stock Unit acquired on April 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediat1ely preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
January 08, 2023 Filed Jan 10, 2023 00:14 UTC AGENUS INC AGEN · Entity 5774 GrantStock Option · Derivative 100,000 $0.00 Strike: $2.40 $0.00
Disclosure

SEC source: 0000899243-23-001364 · doc4.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-01-08

F1 · derivative.exercise_date: Options of Common Stock were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan (the "2019 Plan") on January 8, 2023. Options will vest on January 8, 2024.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 16:20 UTC AGENUS INC AGEN · Entity 5774 GrantCommon Stock 7,239 $2.59 $18,749.01
Disclosure

SEC source: 0000899243-23-000500 · doc4.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,725

F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock.

F2 · price: $2.590 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 17:05 UTC AGENUS INC AGEN · Entity 5774 GrantCommon Stock 7,216 $2.60 $18,747.17
Disclosure

SEC source: 0000899243-22-032915 · doc4.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,486

F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock.

F2 · price: $2.598 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 19:51 UTC AGENUS INC AGEN · Entity 5774 GrantCommon Stock 10,138 $1.85 $18,755.30
Disclosure

SEC source: 0000899243-22-025322 · doc4.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,270

F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock.

F2 · price: $1.85 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued.

F3 · balance_after: The number of shares owned following the reported transaction includes 55,750 shares beneficially owned by the reporting person at the time she was appointed a director, which shares were reported on a Form 3 filed on October 13, 2020. The reporting person has continued to beneficially own such shares since October 13, 2020, but they were inadvertently omitted from Form 4 filings previously filed by the reporting person.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 22:35 UTC AGENUS INC AGEN · Entity 5774 GrantCommon Stock 6,811 $2.75 $18,750.68
Disclosure

SEC source: 0000899243-22-013872 · doc4.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,382

F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock.

F2 · price: $2.753 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued.

Read SEC document
February 04, 2022 Filed Feb 8, 2022 23:09 UTC AGENUS INC AGEN · Entity 5774 GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $2.39 $0.00
Disclosure

SEC source: 0000899243-22-005238 · doc4.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2032-02-04

F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan, as amended, and will vest on February 4, 2023.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 19:59 UTC AGENUS INC AGEN · Entity 5774 GrantCommon Stock 4,677 $4.01 $18,754.77
Disclosure

SEC source: 0000899243-22-000851 · doc4.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,571

F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock.

F2 · price: $4.009 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 23:18 UTC AGENUS INC AGEN · Entity 5774 GrantCommon Stock 3,257 $5.76 $18,760.32
Disclosure

SEC source: 0000899243-21-039312 · doc4.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,894

F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock.

F2 · price: $5.757 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued.

Read SEC document
July 01, 2021 Filed Jul 2, 2021 23:32 UTC AGENUS INC AGEN · Entity 5774 GrantCommon Stock 4,908 $3.82 $18,748.56
Disclosure

SEC source: 0000899243-21-027354 · doc4.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,637

F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock.

F2 · price: $3.820 is the is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued.

Read SEC document
June 15, 2021 Filed Jul 2, 2021 23:32 UTC AGENUS INC AGEN · Entity 5774 GrantStock Option · Derivative 100,000 $0.00 Strike: $3.18 $0.00
Disclosure

SEC source: 0000899243-21-027354 · doc4.xml · derivative · entry 2

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2030-12-17

F3 · derivative.exercise_date: Option was granted on January 1, 2021, subject to shareholder approval of an increase to the available pool under the Company's 2019 Equity Incentive Plan ("2019 Plan"), which was obtained at the Company's annual shareholder meeting on June 15, 2021. Option awarded in accordance with the 2019 Plan. Option vests in full on December 17, 2022.

Read SEC document
April 01, 2021 Filed Apr 5, 2021 22:56 UTC AGENUS INC AGEN · Entity 5774 GrantCommon Stock 5,092 Not disclosed Not disclosed
Disclosure

SEC source: 0001745285-21-000017 · primary_doc.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,729

F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock.

F2 · price: $3.682 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 22:58 UTC AGENUS INC AGEN · Entity 5774 GrantCommon Stock 3,637 $3.78 $13,747.86
Disclosure

SEC source: 0001745285-21-000006 · primary_doc.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,637

F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock.

F2 · price: $3.78 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued.

Read SEC document
December 17, 2020 Filed Dec 21, 2020 19:16 UTC AGENUS INC AGEN · Entity 5774 GrantStock Option (Right to buy) · Derivative 100,000 $0.00 Strike: $3.70 $0.00
Disclosure

SEC source: 0001745285-20-000048 · primary_doc.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2030-12-17

F1 · derivative.exercise_date: Stock Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The Stock Option vests in full on December 17, 2021 (provided Ms. Hirsch continues to serve on the board on such date).

Read SEC document
October 08, 2020 Filed Oct 13, 2020 14:20 UTC AGENUS INC AGEN · Entity 5774 GrantStock Option (Right to buy) · Derivative 100,000 $0.00 Strike: $4.40 $0.00
Disclosure

SEC source: 0001745285-20-000037 · primary_doc.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2030-10-08

F1 · derivative.exercise_date: Stock Option awarded in connection with Ms. Hirsch's appointment to the Board of Directors in accordance with the Agenus Inc. 2019 Equity Incentive Plan and non-employee director compensation program. Stock option vests in three equal annual installments on each of October 8, 2021, 2022 and 2023 (provided Ms. Hirsch maintains a service relationship with the company through each such vesting date).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.